Description
Buy Cabergoline Online
Cabergoline is a long-acting dopamine D2-receptor agonist primarily used to suppress elevated prolactin secretion. It has extensive clinical evidence in hyperprolactinemia and prolactin-secreting pituitary disorders.
Product Information
Cabergoline activates dopamine D2 receptors on pituitary lactotroph cells, reducing prolactin secretion. It is clinically used for hyperprolactinemia and prolactinomas.
How Does It Work?
Cabergoline stimulates D2 receptors and suppresses prolactin release from the pituitary. Lower prolactin can help restore reproductive and endocrine function when hyperprolactinemia is responsible for the disturbance.
Benefits
Prolactin Reduction
In a large study of 455 patients with pathological hyperprolactinemia, cabergoline normalized prolactin levels in 86% of participants.
Prolactinoma Research
Cabergoline has been extensively studied in patients with microprolactinomas and macroprolactinomas, including effects on tumor size.
Reproductive Function
Reduction of elevated prolactin can help restore menstrual cycles, gonadal function, and fertility in appropriate patients.
Dopamine-Agonist Research
Cabergoline’s strong and long-lasting D2 activity makes it an important compound for studying dopaminergic regulation of pituitary hormone secretion.
Side Effects
Potential adverse effects include nausea, headache, dizziness, fatigue, constipation, and low blood pressure. Long-term exposure, particularly at higher cumulative doses, has also raised concerns regarding cardiac-valve effects.
Dosage
In a large hyperprolactinemia study, the median starting dose was 1 mg per week, with many patients subsequently controlled on 0.5 mg per week. Actual dosing depends on the clinical indication and patient response.
Where to Buy Cabergoline
Purerawz does not directly sell cabergoline. Readers should verify product identity, strength, purity, and appropriate regulatory status.
References
Verhelst J, Abs R, Maiter D, et al. Cabergoline in the treatment of hyperprolactinemia: a study in 455 patients. J Clin Endocrinol Metab. 1999;84(7):2518-2522..
Purerawz Disclaimer
Purerawz does not sell, manufacture, stock, dispense, or directly supply any of the products discussed on this website. Purerawz is an independent information and affiliate platform. Where available, links may direct readers to independent third-party suppliers, and Purerawz may receive a commission from qualifying purchases at no additional cost to the reader.
The information on these pages is provided for educational and informational purposes only. Dosage figures may reflect published research protocols or reported community use and should not be interpreted as personalized medical instructions. Research findings, particularly animal and early-stage studies, do not necessarily translate into established human benefits or safety.
Reviews
There are no reviews yet.